![Stephanie Graff: Joint EANM-SNMMI guideline on the role of 2-[18F]FDG PET/CT in no special type breast cancer](https://oncodaily.com/pub/uploads/2024/05/Screenshot-2024-05-14-at-11.49.03 PM-1.png)
Stephanie Graff: Joint EANM-SNMMI guideline on the role of 2-[18F]FDG PET/CT in no special type breast cancer
Stephanie Graff shared a post on X:
“Out now Joint EANM-SNMMI guideline on the role of 2-[18F]FDG PET/CT in no special type breast cancer
Endorsed by European Association of Nuclear Medicine, Society of Nuclear Medicine and Molecular Imaging, The American College of Radiology, European Society of Surgical Oncology, European Society for Radiotherapy and Oncology, European Society Of Breast Imaging.”
Read the article.
Source: Stephanie Graff/X
OncoDaily
Stephanie L. Graff is the Director of the Breast Oncology Program at Lifespan Cancer Institute at the Legorreta Cancer Center at Brown University and co-leader of the Breast Cancer Translational Research Disease Group. She is an Associate Professor of Medicine at the Warren-Alpert School of Medicine. She also serves as a medical advisor to the Dr. Susan Love Foundation for Breast Cancer Research, is an Associate Editor of Cancer Medicine, and chairs the editorial board of Oncology Times.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023